StockMacro
Company, fund or insider

Help

Menu

Healthcare Services

$24.72 +22% in 6 monthsMarket cap $1.7B

HCSG on XNAS, Health Care, Healthcare Services Group, job postings

Measures activity, not value. Not investment advice.

Profit rose 164% to $104.9M while the stock gained 43% in a year.

  • GoodLatest quarter revenue rose 3.3% to $479.6M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.

Industry
Services-nursing & personal care facilities (Health Care)
Employees
36,000
Website
hcsgcorp.com
Listed
Nasdaq, US
Last results
21 Oct 2026
Next results
expected around 10 Feb 2027 (an estimate: a year ago it reported on 11 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $479.6M, net income $24.9M.
Quarter to 31 Dec 2021: revenue $420.4M, net income $2.1MQuarter to 31 Dec 2021: revenue $420.4M, net income $2.1MQuarter to 31 Mar 2022: revenue $426.8M, net income $11.3MQuarter to 31 Mar 2022: revenue $426.8M, net income $11.3MQuarter to 30 Jun 2022: revenue $424.9M, net income $6.8MQuarter to 30 Jun 2022: revenue $424.9M, net income $6.8MQuarter to 30 Sep 2022: revenue $414.5M, net income $322KQuarter to 30 Sep 2022: revenue $414.5M, net income $322KQuarter to 31 Dec 2022: revenue $424.0M, net income $16.2MQuarter to 31 Dec 2022: revenue $424.0M, net income $16.2MQuarter to 31 Mar 2023: revenue $417.2M, net income $12.7MQuarter to 31 Mar 2023: revenue $417.2M, net income $12.7MQuarter to 30 Jun 2023: revenue $418.9M, net income $8.6MQuarter to 30 Jun 2023: revenue $418.9M, net income $8.6MQuarter to 30 Sep 2023: revenue $411.4M, net income -$5.5MQuarter to 30 Sep 2023: revenue $411.4M, net income -$5.5MQuarter to 31 Dec 2023: revenue $423.8M, net income –Quarter to 31 Mar 2024: revenue $423.4M, net income $15.3MQuarter to 31 Mar 2024: revenue $423.4M, net income $15.3MQuarter to 30 Jun 2024: revenue $426.3M, net income -$1.8MQuarter to 30 Jun 2024: revenue $426.3M, net income -$1.8MQuarter to 30 Sep 2024: revenue $428.1M, net income $14.0MQuarter to 30 Sep 2024: revenue $428.1M, net income $14.0MQuarter to 31 Dec 2024: revenue $437.8M, net income –Quarter to 31 Mar 2025: revenue $447.7M, net income $17.2MQuarter to 31 Mar 2025: revenue $447.7M, net income $17.2MQuarter to 30 Jun 2025: revenue $458.5M, net income -$32.4MQuarter to 30 Jun 2025: revenue $458.5M, net income -$32.4MQuarter to 30 Sep 2025: revenue $464.3M, net income $43.0MQuarter to 30 Sep 2025: revenue $464.3M, net income $43.0MQuarter to 31 Dec 2025: revenue $466.7M, net income $31.2MQuarter to 31 Dec 2025: revenue $466.7M, net income $31.2MQuarter to 31 Mar 2026: revenue $462.8M, net income $26.1MQuarter to 31 Mar 2026: revenue $462.8M, net income $26.1MQuarter to 30 Jun 2026: revenue $470.8M, net income $22.7MQuarter to 30 Jun 2026: revenue $470.8M, net income $22.7MQuarter to 30 Sep 2026: revenue $479.6M, net income $24.9MQuarter to 30 Sep 2026: revenue $479.6M, net income $24.9M
31 Dec 2021RevenueNet incomeNet losstallest bar $479.6M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$479.6M$24.9M
30 Jun 2026$470.8M$22.7M
31 Mar 2026$462.8M$26.1M
31 Dec 2025$466.7M$31.2M
30 Sep 2025$464.3M$43.0M
30 Jun 2025$458.5M-$32.4M
31 Mar 2025$447.7M$17.2M
31 Dec 2024$437.8M–
30 Sep 2024$428.1M$14.0M
30 Jun 2024$426.3M-$1.8M
31 Mar 2024$423.4M$15.3M
31 Dec 2023$423.8M–
30 Sep 2023$411.4M-$5.5M
30 Jun 2023$418.9M$8.6M
31 Mar 2023$417.2M$12.7M
31 Dec 2022$424.0M$16.2M
30 Sep 2022$414.5M$322K
30 Jun 2022$424.9M$6.8M
31 Mar 2022$426.8M$11.3M
31 Dec 2021$420.4M$2.1M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.9B $1.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +4.0% +9.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $104.9M $39.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $1.48 $0.53
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 16.1% 12.5% 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -9.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 5.6% 2.2% -7.6%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 20.4% -44.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $106.7M $157.9M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $168.8M $177.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$168.8M (net cash) -$177.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $7.88
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 15.9 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.89 3.2
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.80 3.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.1 2.2

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Healthcare ServicesHCSG (this company) $1.7B15.90.89+4.0%5.6%
Sonida Senior LivingSNDA $1.5Bloss2.4+70%-20.3%
Brookdale Senior LivingBKD $2.1Bloss0.72-8.4%-1.3%
Ultragenyx PharmaceuticalRARE $1.7Bloss2.3+16%-71.7%
Dentsply SironaXRAY $1.7Bloss0.46-1.4%-3.4%
Agios PharmaceuticalsAGIO $1.7Bloss11.7+214%-265%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+3.3%

$479.6M vs $464.3M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+55%

$2.1M vs $1.3M (quarter ended 30 Sep 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$458K

bought $0, sold $458K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+3.0%

276 13F filers vs 268

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

68.0M shares held by 13F filers (30 Sep 2026) of 67.4M outstanding (21 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.7%

2.5M shares sold short (30 Oct 2026) of 67.4M outstanding (21 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.7

2.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-8.6%

2.7M shares sold short in the report before, 2.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

54%

54% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

110

110 articles in the last 7 days; its usual week has 8.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

13×

110 articles in the last 7 days; its usual week has 8.5.

Price $24.72 on 20 Nov 2026, +43% over 12 months (12-month range $17.32 to $26.54)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $3.8M in the last 12 months (the 12 months before: -$301K).
Revenue per quarter. Revenue $479.6M in the latest quarter, +3.3% on a year earlier.
Capital spending per quarter. Capital spending $2.1M in the latest quarter, +55% on a year earlier.
Institutional holders (13F filers). 276 13F filers reported holding it in the latest 13F quarter, +30% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
9 Sep 20248-K and other filingsDirector or officer change
9 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Nov 2021: -$94K published
Month from 1 Mar 2023: -$13K published
Month from 1 Jul 2023: $15K published
Month from 1 Mar 2024: -$14K published
Month from 1 Feb 2025: -$18K published
Month from 1 Jul 2025: -$283K published
Month from 1 Feb 2026: -$3.0M published
Month from 1 Aug 2026: -$362K published
Month from 1 Oct 2026: -$458K published
Revenue per quarter
Quarter ended 31 Dec 2021: $420.4M, -0.6% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $426.8M, +4.7% on a year earlier; public on 23 Apr 2022
Quarter ended 30 Jun 2022: $424.9M, +6.7% on a year earlier; public on 23 Jul 2022
Quarter ended 30 Sep 2022: $414.5M, -0.3% on a year earlier; public on 22 Oct 2022
Quarter ended 31 Dec 2022: $424.0M, +0.8% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $417.2M, -2.2% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $418.9M, -1.4% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $411.4M, -0.7% on a year earlier; public on 28 Oct 2023
Quarter ended 31 Dec 2023: $423.8M, 0% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $423.4M, +1.5% on a year earlier; public on 27 Apr 2024
Quarter ended 30 Jun 2024: $426.3M, +1.8% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $428.1M, +4.1% on a year earlier; public on 26 Oct 2024
Quarter ended 31 Dec 2024: $437.8M, +3.3% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $447.7M, +5.7% on a year earlier; public on 26 Apr 2025
Quarter ended 30 Jun 2025: $458.5M, +7.6% on a year earlier; public on 26 Jul 2025
Quarter ended 30 Sep 2025: $464.3M, +8.5% on a year earlier; public on 25 Oct 2025
Quarter ended 31 Dec 2025: $466.7M, +6.6% on a year earlier; public on 14 Feb 2026
Quarter ended 31 Mar 2026: $462.8M, +3.4% on a year earlier; public on 25 Apr 2026
Quarter ended 30 Jun 2026: $470.8M, +2.7% on a year earlier; public on 25 Jul 2026
Quarter ended 30 Sep 2026: $479.6M, +3.3% on a year earlier; public on 24 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $1.5M, +17% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $1.4M, +66% on a year earlier; public on 23 Apr 2022
Quarter ended 30 Jun 2022: $1.2M, -5.6% on a year earlier; public on 23 Jul 2022
Quarter ended 30 Sep 2022: $1.6M, -26% on a year earlier; public on 22 Oct 2022
Quarter ended 31 Dec 2022: $1.1M, -28% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $1.0M, -28% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $1.1M, -7.3% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $1.9M, +20% on a year earlier; public on 28 Oct 2023
Quarter ended 31 Dec 2023: $1.4M, +34% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $2.2M, +118% on a year earlier; public on 27 Apr 2024
Quarter ended 30 Jun 2024: $1.3M, +21% on a year earlier; public on 27 Jul 2024
Quarter ended 30 Sep 2024: $1.4M, -25% on a year earlier; public on 26 Oct 2024
Quarter ended 31 Dec 2024: $1.4M, -0.4% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $1.7M, -21% on a year earlier; public on 26 Apr 2025
Quarter ended 30 Jun 2025: $1.4M, +3.6% on a year earlier; public on 26 Jul 2025
Quarter ended 30 Sep 2025: $1.3M, -4.5% on a year earlier; public on 25 Oct 2025
Quarter ended 31 Dec 2025: $1.4M, -3.3% on a year earlier; public on 14 Feb 2026
Quarter ended 31 Mar 2026: $1.4M, -20% on a year earlier; public on 25 Apr 2026
Quarter ended 30 Jun 2026: $1.6M, +20% on a year earlier; public on 25 Jul 2026
Quarter ended 30 Sep 2026: $2.1M, +55% on a year earlier; public on 24 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 201; public on 14 Feb 2022
31 Mar 2022 report: 195; public on 16 May 2022
30 Jun 2022 report: 203; public on 15 Aug 2022
30 Sep 2022 report: 189; public on 14 Nov 2022
31 Dec 2022 report: 183; public on 14 Feb 2023
31 Mar 2023 report: 204; public on 15 May 2023
30 Jun 2023 report: 185; public on 14 Aug 2023
30 Sep 2023 report: 188; public on 14 Nov 2023
31 Dec 2023 report: 184; public on 14 Feb 2024
31 Mar 2024 report: 205; public on 15 May 2024
30 Jun 2024 report: 187; public on 14 Aug 2024
30 Sep 2024 report: 197; public on 14 Nov 2024
31 Dec 2024 report: 198; public on 14 Feb 2025
31 Mar 2025 report: 198; public on 15 May 2025
30 Jun 2025 report: 210; public on 14 Aug 2025
30 Sep 2025 report: 213; public on 14 Nov 2025
31 Dec 2025 report: 241; public on 17 Feb 2026
31 Mar 2026 report: 254; public on 15 May 2026
30 Jun 2026 report: 268; public on 14 Aug 2026
30 Sep 2026 report: 276; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is deferred revenue / contract liabilities at $6.8M (30 Sep 2026), 9.7× its normal quarter; higher than 79% of its own history.
  • Insider net buying (open market): Insiders sold a net $3.8M in the last 12 months (the 12 months before: -$301K).
  • Revenue per quarter: Revenue $479.6M in the latest quarter, +3.3% on a year earlier.
  • Capital spending per quarter: Capital spending $2.1M in the latest quarter, +55% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 55 insider trades

Last 90 days: 1 sale, $458K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
27 Oct 2026Jason J BundickEVP/Gen. Counsel/Corp. Secty.Sell18,239$25.11$458KForm 4
5 Aug 2026Andrew KushEVP & Chief Operating OfficerSell15,598$23.24$362KForm 4
26 Feb 2026Andrew M BrophySVP & Chief Accounting OfficerSellplanned in advance (10b5-1)2,490$21.75$54KForm 4
20 Feb 2026Patrick J OrrEVP & Chief Revenue OfficerSell44,615$20.53$916KForm 4
19 Feb 2026John Christopher SheaEVP & Chief Admin. OfficerSellafter exercising options54,357$20.41$1.1MForm 4
19 Feb 2026Patrick J OrrEVP & Chief Revenue OfficerSellafter exercising options45,500$20.54$935KForm 4
30 Jul 2025John Christopher SheaEVP & Chief Admin. OfficerSell21,368$13.25$283KForm 4
26 Feb 2025Andrew M BrophySVP & Chief Accounting OfficerSellplanned in advance (10b5-1)1,744$10.45$18KForm 4

276 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 34 opened a position, 29 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.11.5M17.0%$234.2M+77K+0.7%
Vanguard Portfolio Management LLC5.5M8.10%$111.6M+378K+7.4%
American Century Companies Inc3.3M4.90%$67.6M+645K+24%
Vanguard Capital Management LLC2.8M4.15%$57.3M-241K-7.9%
State Street Corp2.8M4.13%$56.9M-133K-4.5%
Geode Capital Management, LLC2.6M3.79%$52.3M-6,654-0.3%
Dimensional Fund Advisors LP2.5M3.75%$51.7M+45K+1.8%
Royce & Associates LP2.0M2.94%$40.5M-257K-11%
Arrowstreet Capital, Limited Partnership1.5M2.28%$31.4M+92K+6.4%
FMR LLC (Fidelity)1.4M2.13%$29.4M-860K-37%

Company events

All 12 company events

In 12 months: 2 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
7 Oct 2026Signed a major agreement8-K
13 Apr 2026Signed a major agreementSame filing: took on new debt8-K
9 Sep 2024Director or officer change8-K
28 Nov 2022Signed a major agreementSame filing: took on new debt8-K
20 Oct 2021Director or officer change8-K
24 Aug 2021Director or officer change8-K
10 Feb 2021Director or officer change8-K
12 Nov 2020Director or officer change8-K

Layoff notices

All 3 layoff notices

No notice in 12 months; the latest is dated 1 Dec 2013. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Dec 2013Healthcare Services GroupManchester, NJ3326 Feb 2014Notice
1 Sep 2013Healthcare Services GroupBarnegat, NJ15026 Nov 2013Notice
1 Nov 2011Healthcare Services Group, Inc.Bensalem, NJ1427 Apr 2012Notice

The 5 newest of 694 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 7 Feb 2025Institutional holdings record

    Wealthfront Advisers LLC opened a $391.0M position (2024Q4 13F)

  2. 9 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 9 Sep 2024Filings record

    Director or officer change

  4. 4 Jul 2023Insiders record

    Simmons Kurt JR (director) bought 1,005 shares of HCSG ($15,005) (dated 3 Jul 2023)

  5. 20 Oct 2021Filings record

    Director or officer change

  6. 24 Aug 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 24 Aug 2021Filings record

    Director or officer change

  8. 10 Feb 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 10 Feb 2021Filings record

    Director or officer change

  10. 12 Nov 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  11. 12 Nov 2020Filings record

    Director or officer change

  12. 11 Feb 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 11 Feb 2020Filings record

    Director or officer change

  14. 23 Jul 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 23 Jul 2019Filings record

    Director or officer change

  16. 4 Mar 2019Filings record

    Report will be filed late

  17. 1 Jan 2014Layoff notices record

    WARN notice: Healthcare Services Group, 33 workers, Manchester, NJ (dated 1 Dec 2013)

  18. 1 Oct 2013Layoff notices record

    WARN notice: Healthcare Services Group, 150 workers, Barnegat, NJ (dated 1 Sep 2013)

  19. 1 Dec 2011Layoff notices record

    WARN notice: Healthcare Services Group, Inc., 14 workers, Bensalem, NJ (dated 1 Nov 2011)

Not listed: 182 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000731012
Ticker
HCSG
Domain
hcsgcorp.com
Employer name
Healthcare Services Group, Inc. (1 unverified)
Hq location
PA|BENSALEM|19020 (1 unverified)
Name
Core Procure, LLC, ELuminate, LLC, HCSG Central, LLC, HCSG Clinical Services, LLC and 9 more
  • SEC Form 13F institutional holdings1 record, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)136 records26 Jan 2016 to 23 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)911 data points31 Dec 2007 to 21 Oct 2026
  • SEC Form 4 insider transactions55 records, 188 data points24 Feb 2016 to 27 Oct 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • WARN layoff notices (state labor agencies)3 records, 9 data points31 Oct 2011 to 1 Dec 2013